Study identifies key risk factors driving MASLD across populations
Summary
Metabolic dysfunction-associated steatotic liver disease (MASLD) affects approximately 32% of the US adult population.
Description
Metabolic dysfunction-associated steatotic liver disease (MASLD) affects approximately 32% of the US adult population.
Original reporting
AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.
Open original source